glp 1 weight loss howard county md GLP-1 Specialist in Langhorne and Philadelphia, PA Losing the Weight Loss Meds:

[14], in which telemetric intracranial pressure monitors allowed for continuous ICP recording

2025, e70103, Rentzeperi, Elpiniki, et al

& Hanauske, A.-R

Of the 75% who report digestive side effects, symptoms extend well beyond the nausea most commonly discussed in coverage of these medications, underscoring why a one-size-fits-all approach falls short and personalized care matters: 32% nausea 26% constipation 25% bloating or gas 21% acid reflux 21% feeling uncomfortably full after eating very little 21% diarrhea 18% abdominal pain 14% loss of appetite to the point of concern 10% vomiting From Trade-Off to Solution These findings land as GLP-1 use accelerates

The first three to six months after dose reduction carry the highest risk for metabolic relapse